Actionable news
0
All posts from Actionable news
Actionable news in VRX: VALEANT PHARMACEUTICALS INTERNATIONAL,

2 Drug Stocks' Earnings to Watch this Week: VRX and XBIT

The Q1 earnings season is almost coming to an end with 91.8% (as of May 13) of the S&P 500 members having already reported results. The Retail sector is the only one at this stage that has a sizeable number of reports still to come.

But how has this particular earnings season panned out so far? By now it is no secret that the season has been marked by “low expectations.” Though growth was hard to come by, results were not as dismal as was widely expected with several companies delivering positive surprises for both earnings as well as revenues.

Still, Q1 is headed to be the fourth straight quarter of earnings declines for the index. And what is more concerning, this trend of earnings declines is expected to continue into the second quarter as well. As most of the remaining companies report Q1 results over the coming days, things will gain more clarity.

With the majority of pharma and major biotech companies having released their earnings results, Medical is one of the few sectors witnessing earnings and revenue growth in Q1. Our Q1 scorecard shows that 96.2% of the Medical sector has reported results with earnings growth of 7.7% on revenue...


More